MAPT and Alzheimer disease: A recent study showed that sulfhydration of Akt, detected in the postmortem brains of patients with AD, inhibits its interaction with GSK3β and subsequently decreases the Ser9 phosphorylation of GSK3β, then, the activated GSK3β promotes tau phosphorylation and cognitive dysfunction (Sen et al., 2020).